APPLICATION
ANDA076110
TYPE
ANDA
ORIGINAL APPROVAL
2002-05-14
LATEST ACTION
2019-03-10
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
TORSEMIDEDiscontinued
TORSEMIDE 100MG · TABLET · ORAL
TORSEMIDEDiscontinued
TORSEMIDE 10MG · TABLET · ORAL
TORSEMIDEDiscontinued
TORSEMIDE 20MG · TABLET · ORAL
TORSEMIDEDiscontinued
TORSEMIDE 5MG · TABLET · ORAL
Approval history
2019-03-10Labeling · Supplement 6 · standardAP
2010-04-16Labeling · Supplement 5AP
2002-11-06Manufacturing (CMC) · Supplement 1AP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.